All coronavirus articles
-
OpinionBert Meijer: ‘I'm in love with molecules’
The pioneering organic chemist discusses the rewards of working with young people and the role of chemistry in fighting Covid-19
-
Business
Chemicals industry roundup 2020
Pandemic provides impetus to re-tune supply chains for resilience and sustainability
-
Business
Pharmaceuticals roundup 2020
Alongside the race for Covid-19 treatments and vaccines, the industry has maintained momentum
-
Opinion
Chemists amid coronavirus: 2020 in review
How the pandemic has changed the way we live and work around the world
-
Careers
Underrepresented scientists hardest hit by pandemic
The effects of Covid-19 have exacerbated existing inequalities in academia
-
Business
Cybercriminals target Covid-19 vaccines
Officials in the UK and US warn of threat from cyber-attacks that steal data related to Covid-19 vaccines and aim to disrupt the supply chain
-
Feature
2020: the year the world changed
Andy Extance discovers how scientists around the world have responded to the pandemic, working on solutions from drugs and vaccines to hand sanitiser and PPE
-
Business
Pfizer–BioNTech vaccine gains emergency approvals in US, Canada and beyond
UK begins vaccinating vulnerable populations after early authorisation
-
Opinion
Stirring in my sleep
Cut off from the lab after 40 years, Derek Lowe returns to the bench in his dreams
-
Research
Animal tests reveal synthetic decoy protein protects against coronavirus
Protein designed from scratch binds Sars-CoV-2 with high affinity and specificity
-
Business
UK grants Pfizer–BioNTech Covid-19 vaccine emergency approval
Regulators around the world working towards accelerated decisions on vaccine data
-
-
Business
Oxford–AstraZeneca vaccine joins others with promising interim data
Cheap and fridge-stable candidate at least 60% and up to 90% effective at preventing disease
-
Business
Moderna and Pfizer’s Covid-19 vaccines add more encouraging data
Pfizer–BioNTech reach safety threshold for emergency authorisation, while Moderna’s data peek suggests 95% efficacy
-
News
Scientists urge caution on use of lateral flow tests to screen for Covid-19
Preliminary review reveals devices perform poorly at identifying people infected with Sars-CoV-2
-
Opinion
Chemists amid coronavirus: Justin Houseknecht
An organic chemist in the US has used the pandemic to try to spark change in how chemistry is taught at universities
-
Careers
Studying chemistry in the age of Covid-19
University students across the UK are enjoying a mixture of online and practical learning as departments adjust to new restrictions
-
Opinion
The ins and outs of vaccine trials
Derek Lowe lays out how the trials work, and why they get paused and restarted
-
Opinion
A promising peep at Covid-19 vaccine efficacy
Pfizer–BioNTech’s will need to be one of many if we are to overcome the pandemic
-
Business
Early indications suggest Pfizer–BioNTech’s Covid-19 vaccine is effective
Company claims 90% efficacy at preventing disease, but experts call for data rather than press releases
